Yield Growth Subsidiary Flourish Mushroom Labs Announces Agreement to Establish Laboratory to Grow and Research Psilocybin Mushrooms
The Yield Growth Corp. Accelerating Global Distribution and Seizing Opportunities in Psychedelic Research
Listen Live: The Yield Growth Corp. to Host Live Webcast Featuring a “2020 Outlook on the Psychedelic Mushroom Boom”
Yield Growth Announces Completion of Production of 5 SKU’s of Wright & Well CBD and THC Products in Oregon
Yield Growth Subsidiary Flourish Mushroom Labs Files for U.S. Patent to use Serotonin Antagonists from Psychedelic Mushrooms for Weight Loss
Yield Growth Subsidiary Yield Botanicals signs LOI to Acquire Canniva Capital and enter European CBD Market
Yield Growth President and CEO, Penny White, to Speak at CannaBiz Innovations Hub Conference in London
EMP METALS ADVANCES CONSTRUCTION OF PROJECT AURORA DEMONSTRATION PLANT BY COMPLETING INTERIOR FINISHING
FDA Accepts LEQEMBI® IQLIK Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
FDA Accepts LEQEMBI® IQLIKTM Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
